GENEVA, Sept. 24 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2026/019573) for “OLIGONUCLEOTIDE COMPOSITIONS AND USES THEREOF FOR INHIBITING DUX4 EXPRESSION”. With publication no. WO/2026/198559, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....